LOCALLY ADVANCED CERVICAL CANCER
Clinical trials for LOCALLY ADVANCED CERVICAL CANCER explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED CERVICAL CANCER trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED CERVICAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immunotherapy boosts standard treatment for cervical cancer?
Disease control CompletedThis study tested whether adding the immunotherapy drug atezolizumab to standard chemoradiotherapy helps people with locally advanced cervical cancer. About 189 participants received either the combination or standard treatment alone. The goal was to see if the drug delays cancer…
Matched conditions: LOCALLY ADVANCED CERVICAL CANCER
Phase: PHASE2 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated May 26, 2026 10:05 UTC
-
Immunotherapy plus chemoradiation shows promise in cervical cancer trial
Disease control CompletedThis early-phase study tested whether adding the immunotherapy drug nivolumab to standard chemoradiation is safe for people with locally advanced cervical cancer. Twenty-one adults took part, receiving nivolumab alongside radiation and cisplatin, followed by up to six months of n…
Matched conditions: LOCALLY ADVANCED CERVICAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: Institut Curie • Aim: Disease control
Last updated May 26, 2026 09:50 UTC